Gefitinib-induced epidermal growth factor receptor-independent keratinocyte apoptosis is mediated by the JNK

P-H Lu1, T-C Kuo, K-C Chang

  • 1Department of Dermatology, Taipei City Hospital, Zhongxiao Branch, Taipei, Taiwan.

Abstract

Insights

Gefitinib causes skin toxicity through a pathway independent of epidermal growth factor receptor (EGFR) inhibition. This toxicity involves the activation of JNK signaling, leading to keratinocyte apoptosis.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Gefitinib (ZD1839) is a targeted therapy inhibiting epidermal growth factor receptor (EGFR) tyrosine kinase, effective against various cancers.
  • Skin toxicity is a common side effect of gefitinib, often linked to EGFR pathway inhibition.
  • Potential EGFR-independent mechanisms contributing to gefitinib-induced skin toxicity require investigation.

Purpose of the Study:

  • To elucidate EGFR-independent mechanisms underlying gefitinib-induced skin toxicity.
  • To investigate the role of specific signaling pathways in gefitinib's effects on keratinocytes.

Main Methods:

  • Utilized HaCaT keratinocytes and A549/PC9 lung cancer cells treated with gefitinib.
  • Assessed cell viability via MTT assay following EGFR gene silencing.
  • Analyzed signaling pathways using immunoblotting and evaluated keratinocyte apoptosis through nuclear condensation and flow cytometry.

Main Results:

  • Gefitinib exhibited cytotoxicity in HaCaT cells even after EGFR gene silencing, confirming an EGFR-independent mechanism.
  • Gefitinib dose-dependently increased phosphorylation of p38 MAPK and JNK in HaCaT cells.
  • Inhibition of JNK signaling attenuated gefitinib-induced cytotoxicity and apoptosis; increased phosphorylated JNK was observed in patient skin lesions.

Conclusions:

  • Gefitinib induces keratinocyte apoptosis via an EGFR-independent pathway.
  • JNK activation is a key mechanism in gefitinib-induced skin toxicity.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...